Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: Revolo Biotherapeutics
Peptide Shows Promise as an Allergen-Agnostic Treatment for Food Allergy
Dave Bloom
-
2023/03/01
Revolog presents new data demonstrating long-lasting effect of '1104 candidate.
Company Completes Enrollment for Phase 2 Trial of “Immune Resetting” Peptide...
News Wire ~ 3rd Party Press Release
-
2023/01/05
Topline data anticipated in Q2 2023.
Revolo Biotherapeutics Announces Open Enrollment for Phase 2 Clinical Trial of...
News Wire ~ 3rd Party Press Release
-
2021/10/28
Revolo Biotherapeutics announced it has activated clinical sites and opened enrollment in a Phase 2 clinical trial of its eosinophilic esophagitis therapy.